"HIV Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
Descriptor ID |
D015658
|
MeSH Number(s) |
C02.782.815.616.400 C02.800.801.400 C20.673.480
|
Concept/Terms |
HIV Infections- HIV Infections
- HIV Infection
- Infection, HIV
- Infections, HIV
- HTLV-III-LAV Infections
- HTLV III LAV Infections
- HTLV-III-LAV Infection
- Infection, HTLV-III-LAV
- Infections, HTLV-III-LAV
- T-Lymphotropic Virus Type III Infections, Human
- T Lymphotropic Virus Type III Infections, Human
- HTLV-III Infections
- HTLV III Infections
- HTLV-III Infection
- Infection, HTLV-III
- Infections, HTLV-III
HIV Coinfection- HIV Coinfection
- Coinfection, HIV
- Coinfections, HIV
- HIV Coinfections
|
Below are MeSH descriptors whose meaning is more general than "HIV Infections".
Below are MeSH descriptors whose meaning is more specific than "HIV Infections".
This graph shows the total number of publications written about "HIV Infections" by people in this website by year, and whether "HIV Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 0 | 2 |
1995 | 2 | 0 | 2 |
1996 | 5 | 1 | 6 |
1997 | 2 | 2 | 4 |
1998 | 3 | 3 | 6 |
1999 | 6 | 0 | 6 |
2000 | 9 | 1 | 10 |
2001 | 6 | 2 | 8 |
2002 | 8 | 1 | 9 |
2003 | 8 | 1 | 9 |
2004 | 9 | 0 | 9 |
2005 | 9 | 2 | 11 |
2006 | 8 | 1 | 9 |
2007 | 14 | 0 | 14 |
2008 | 11 | 5 | 16 |
2009 | 18 | 5 | 23 |
2010 | 14 | 2 | 16 |
2011 | 16 | 2 | 18 |
2012 | 24 | 0 | 24 |
2013 | 25 | 4 | 29 |
2014 | 23 | 3 | 26 |
2015 | 26 | 1 | 27 |
2016 | 38 | 6 | 44 |
2017 | 45 | 5 | 50 |
2018 | 42 | 3 | 45 |
2019 | 37 | 2 | 39 |
2020 | 50 | 3 | 53 |
2021 | 52 | 1 | 53 |
2022 | 47 | 0 | 47 |
2023 | 43 | 1 | 44 |
2024 | 36 | 2 | 38 |
To return to the timeline,
click here.
Below are the most recent publications written about "HIV Infections" by people in Profiles.
-
Mapping Implementation Strategies to Address Barriers to Pre-Exposure Prophylaxis Use Among Women Through POWER Up (Pre-Exposure Prophylaxis Optimization Among Women to Enhance Retention and Uptake): Content Analysis. JMIR Form Res. 2024 Nov 15; 8:e59800.
-
Knowledge, Attitudes, and Perspectives of Women Who Have Migrated from Sub-Saharan Africa to France Toward HIV Pre-Exposure Prophylaxis in a Family Planning Center. AIDS Patient Care STDS. 2024 Nov; 38(11):507-516.
-
Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir/rilpivirine among early adopters in three U.S. clinics. J Int AIDS Soc. 2024 Nov; 27(11):e26394.
-
Efficacy of Smoking Cessation Interventions among People with HIV in Kenya. NEJM Evid. 2024 Nov; 3(11):EVIDoa2400090.
-
Analyzing Social Support from Facebook on Viral Suppression among Young Black Men Who Have Sex with Men Living with HIV: A Pilot Study. Int J Environ Res Public Health. 2024 Oct 12; 21(10).
-
PrEPárate: Evaluation of a Community-Driven PrEP Social Marketing Intervention Tailored to Latino/a/x Individuals. AIDS Behav. 2024 Dec; 28(12):4069-4078.
-
Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine. Contemp Clin Trials. 2024 Nov; 146:107690.
-
A multiplexed real-time PCR assay for simultaneous quantification of human immunodeficiency virus and Hepatitis B virus for low-and-middle- income countries. J Virol Methods. 2024 Dec; 330:115026.
-
Using GPS-defined venue-based affiliation networks among Black sexually minoritized men and transgender women to identify locations for HIV prevention interventions. Ann Epidemiol. 2024 Aug; 96:80-87.
-
Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People With HIV Who Are Virally Unsuppressed. J Acquir Immune Defic Syndr. 2024 07 01; 96(3):280-289.